Skip to content

A prospective study for laparoscopic low anterior resection of rectum with lateral pelvic lymph node dissection in patients with advanced lower rectal cancer

A prospective study for laparoscopic low anterior resection of rectum with lateral pelvic lymph node dissection in patients with advanced lower rectal cancer - laparoscopic lateral pelvic lymph node dissection in patients with advanced lower rectal cancer

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000014955
Enrollment
22
Registered
2014-09-01
Start date
2014-12-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

advanced lower rectal cancer

Interventions

laparoscopic lateral pelvic lymph node dissection lateral lymph node dissection by open surgery

Sponsors

Chubu Clinical Oncology Group
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Histologically confirmed adenocarcinoma (2)recquirement to all of follows by preoperative diagnostic imaging 1.invasion depth is more than T3, or metastasis in N1, N2 lymph node 2.Main lesion of the tumor is located at the rectum 3.Lower tumor margin is below the peritoneal reflection 4.No extramesorectal lymph node swelling (Shorter diameter is less than 10 mm) 5.No invasion to other organ (s) (3) no past history of pelvic radiation (4)without multiple malignancies (5)Patient age is more than 20 and less than 75 (6)PS: 0, 1 (7)adequate organ function (8) Written informed consent

Exclusion criteria

Exclusion criteria: 1.Multiple malignancies to be treated 2.Pregnant women, possibly pregnant women, wishing to become pregnant, and nursing mothers. 3.Intestinal bleeding, ileus, bowel obstruction or uncontrolled peptic ulcer 4.Uncontrolled severe complications(DM, hypertension, diarrhea, et al.) 5.Massive pleural effusion or ascites that required drainage. 6.Patient with symptomatic cardiovascular disease or asymptomatic disease but has been treated (>=Grade 2 according to NCI-CTCAE ver.4). History of myocardial infarction within a year. 7.With interstitial lung disease or pulmonary fibrosis 8.Continuous systemic steroid therapy (oral or intravenous administration) 9.A history and/or current evidence of significant neurological and/or mental illness 10.Not appropriate for the study at the physician's assessment

Design outcomes

Primary

MeasureTime frame
incidence of complication

Secondary

MeasureTime frame
3-year local recurrence-free survival,3-year recurrece-free survival,recurrence-free survival,overall survival,operative time,intraoperative bleeding,transition to open surgery,completion of surgery, number of dissected lateral lymph node, voiding dysfunction, hospital days after surgery

Countries

Japan

Contacts

Public ContactTetsuya Wada

M's system data center

marobon@dream.com0561-51-5590

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026